Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 37-48 of 605
» View wsbt.com items only
    May 30, 2013 |Story| Baltimore Sun
  1. Glaxo anti-cancer cocktail gets regulatory approval

    <span>After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss -- even the possibility of a suddenly shortened life. For Stratos, of Virginia, and others who have benefitted from a class of revolutionary anti-cancer drugs known as BRAF mutation inhibitors, another tool in the fight against relapse has just been sharpened: Drug maker GlaxoSmithKline received FDA </span><a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm354199.htm"><span>approval</span></a><span> Wednesday for a new cocktail that includes a BRAF-targeting component. </span>
    The Baltimore Sun
    After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss --...

    Tags: Medical Specialization, GlaxoSmithKline PLC, McCormick Place, Health Organizations, Human Genome Sciences Inc.

  2. Jun 1, 2013 |Story| Reuters
  3. Merck KGaA's Erbitux beats Avastin in bowel cancer trial

    Reuters
    FRANKFURT, June 1 (Reuters) - Merck KGaA's cancer drug Erbitux was shown to be more effective at prolonging the lives of bowel cancer patients than Roche's Avastin, Merck said. In a drug trial, the two drugs were each given in combination with Folfiri...

    Tags: Science and Technology, Drugs and Medicines, Lilly Eli & Co, Germany, Health Treatments

  4. May 31, 2013 |Story| Reuters
  5. RPT-PREVIEW-Immunotherapy is not just for melanoma anymore

    Reuters
    (Repeats for wider distribution. No changes to headline or text) By Julie Steenhuysen and Deena Beasley CHICAGO/LOS ANGELES, May 31 (Reuters) - Diagnosed with advanced lung cancer over a year ago, Gabe Tartaglia was loath to undergo the kind of harsh...

    Tags: Health Treatments, Bevacizumab (drug), Cancer, Biotechnology, Chemotherapy

  6. Jun 1, 2013 |Story| Baltimore Sun
  7. Outlook changing for PSA screening

    For nearly a quarter-century, doctors have ordered annual PSA tests for men of a certain age to screen for prostate cancer, despite a lack of evidence that its benefits outweigh the risks &mdash; especially when tiny, slow-growing tumors were detected.
    For nearly a quarter-century, doctors have ordered annual PSA tests for men of a certain age to screen for prostate cancer, despite a lack of evidence that its benefits outweigh the risks — especially when tiny, slow-growing tumors were detected....

    Tags: Death, Erectile Dysfunction, General Practitioners, Prostate Cancer, Symptoms

  8. May 14, 2013 |Story| Los Angeles Times
  9. Decoding Angelina Jolie's double mastectomy and BRCA genes

    Angelina Jolie&rsquo;s revelation that she underwent a preventative double mastectomy may seem like a shocking move to some. But for many women who have dangerous hereditary risks coded into their genes, this kind of <a href="http://www.latimes.com/news/science/sciencenow/la-sci-sn-angelina-jolie-double-mastectomy-breast-cancer-brca1-risk-20130514,0,5010798.story" target="_blank">surgery before cancer strikes</a> serves as a viable alternative that's been growing in popularity over the last few decades, doctors say.
    Los Angeles Times
    Angelina Jolie’s revelation that she underwent a preventative double mastectomy may seem like a shocking move to some. But for many women who have dangerous hereditary risks coded into their genes, this kind of surgery before cancer strikes serves...

    Tags: Ovarian Cancer, Breast Cancer, Tamoxifen (drug), Mastectomy, Angelina Jolie

  10. May 27, 2013 |Story| Chicago Tribune
  11. Voice of the People, May. 27

    Jolie's decision Angelina Jolie's decision to undergo testing for mutations in the BRCA1 and BRCA2 genes and then to undergo a double mastectomy to reduce her risk for breast and ovarian cancer was prompted by her family history. The Society of...

    Tags: Ovarian Cancer, Breast Cancer, Prosecution, Social Issues, Planned Parenthood

  12. May 24, 2013 |Story| Hartford Courant
  13. Double Mastectomy: Choosing A Full Life

    The Hartford Courant
    I was moved by Angelina Jolie's recent revelation that she had a double mastectomy because she has a BRAC gene mutation that indicates a higher risk of getting breast or ovarian cancer. I am BRCA 1 positive and had my breasts removed to reduce my risk...

    Tags: Medical Specialization, Ovarian Cancer, Breast Cancer, Nursing, Mastectomy

  14. May 10, 2013 |Story| Los Angeles Times
  15. Patient is out of network, out of luck

    A worrisome abdominal pain drove Jalal Afshar to seek treatment last year at healthcare giant Kaiser Permanente.
    A worrisome abdominal pain drove Jalal Afshar to seek treatment last year at healthcare giant Kaiser Permanente. The Pasadena resident and Kaiser member had lived for years with a rare condition known as Castleman's disease, which affects the lymph...

    Tags: Science and Technology, Abdominal Pain, Health Treatments, Biotechnology, Chemotherapy

  16. May 22, 2013 |Story| Reuters
  17. Another 3 deals price in US high-yield; Legacy Reserves on tap

    Reuters
    By Joy Ferguson NEW YORK, May 22 (IFR) - Underwriters cleared out another three deals this afternoon for a total of USD1.34bn, while another USD250m bond from Legacy Reserves remained on deck. Bankers said this week that deals haven't been as over-...

    Tags: Petroleum Industry, Radiation Therapy, Mortgages, Banking, Health Treatments

  18. May 14, 2013 |Story| Chicago Tribune
  19. Star's preventive surgery sparks breast cancer debate

    Angelina Jolie's announcement Tuesday that a genetic predisposition to breast and ovarian cancer led her to undergo a preventive double mastectomy has raised both awareness about the procedure and concerns among physicians and other experts.
    Angelina Jolie's announcement Tuesday that a genetic predisposition to breast and ovarian cancer led her to undergo a preventive double mastectomy has raised both awareness about the procedure and concerns among physicians and other experts. The actress...

    Tags: Ovarian Cancer, Breast Cancer, Angelina Jolie, The New York Times, Collagen Injections

  20. May 22, 2013 |Story| Reuters
  21. Immune system cancer drugs tipped to be a $35 bln market

    Reuters
    * Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...

    Tags: GlaxoSmithKline PLC, AstraZeneca Plc, Science and Technology, HIV, Drugs and Medicines

  22. May 21, 2013 |Story| Allentown Morning Call
  23. Elizabeth Vega Casey: Women with breast cancer gene have treatment choices

    The Morning Call may not be The New York Times, but I have to acknowledge that I am not Angelina Jolie either. But there are similarities. Let me explain. Firstly, I want to take a moment to sincerely applaud her decision to reveal through The New York...

    Tags: Lehigh Valley Hospital, Breast Cancer, Tamoxifen (drug), Medical Procedures and Tests, Mastectomy

< Previous1 2 3  4  5 6 7 8 9 10 11-51Next >
Original site for Oncology topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Oncology Photos
Anaiss Cardenas (left), medical assistant with El Centr...
(June 7, 2013)
Dr. Ijaz I. Arshad, medical director of the Cancer Inst...
(May 15, 2013)
Dr. Ijaz I. Arshad
Colleen Kisel of the Pediatric Oncology Treasure Chest...
(April 26, 2013)
Colleen Kisel of the Pediatric Oncology Treasure Chest Foundation